<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Chemoprevention offers a novel approach to control the incidence of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), which is a fatal cause of <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> in both Western and Asia countries </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="18257">Ornithine</z:chebi> decarboxylase (<z:mp ids='MP_0010716'>ODC</z:mp>) functions as a cell transition factor by regulating the biosynthesis of <z:chebi fb="0" ids="51349">polyamines</z:chebi>, which, allied with <z:mpath ids='MPATH_557'>aberrant crypt foci</z:mpath> (ACF) proliferation, cause early lesions of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>This study exemplifies the chemopreventive efficacy of <z:chebi fb="1" ids="4775">ellagic acid</z:chebi> (EA) in 1,2-dimethylhydrazine (DMH) initiated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in rats </plain></SENT>
<SENT sid="3" pm="."><plain>Subcutaneous injection of DMH (40 mg/kg body weight twice a week for 2 weeks) to the rats resulted in elevated expression of <z:mp ids='MP_0010716'>ODC</z:mp>, a genetic marker for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, and its transcription factor myelocytomatosis oncogene (c-myc) </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, increased levels of <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation and <z:chebi fb="0" ids="35923,35924">hydroperoxides</z:chebi> with diminished levels of <z:chebi fb="11" ids="22586">antioxidants</z:chebi> including <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase, catalase, and reduced <z:chebi fb="0" ids="16856">glutathione</z:chebi> were also observed in the tissues of DMH-intoxicated rats </plain></SENT>
<SENT sid="5" pm="."><plain>Oral supplementation of EA significantly influences maintenance of <z:chebi fb="11" ids="22586">antioxidant</z:chebi> status and transcriptional inactivation of <z:mp ids='MP_0010716'>ODC</z:mp> expression, reducing ACF proliferation and/or progression, thus signifying the chemopreventive efficacy of EA against <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>